Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Savvides

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
International Journal of Cardiology|August 10, 2013
Intravascular optical coherence tomographic (OCT) findings late after intracoronary beta brachytherapyR Doustaly, J Siegwald, C Naoum, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 6, 2012
Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatmentA D Anastasilakis, S A Polyzos, P Makras, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 7, 2013
Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatmentA D Anastasilakis, S A Polyzos, P Makras, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
International Journal of Cardiology|August 10, 2013
Intravascular optical coherence tomographic (OCT) findings late after intracoronary beta brachytherapyR Doustaly, J Siegwald, C Naoum, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 6, 2012
Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatmentA D Anastasilakis, S A Polyzos, P Makras, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 7, 2013
Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatmentA D Anastasilakis, S A Polyzos, P Makras, et al.
Pageof 2